Literature DB >> 4364334

Hormonal control of lysosomal enzyme release from human neutrophils. Effects of autonomic agents on enzyme release, phagocytosis, and cylic nucleotide levels.

L J Ignarro, T F Lint, W J George.   

Abstract

The purpose of this investigation was to examine the effects of autonomic neurohormones, cyclic nucleotides, and related agents on the immunologic discharge of lysosomal enzymes from, and phagocytosis by, purified human neutrophils. In order to discern the possible intracellular mechanisms by which certain neurohormones influence neutrophil function, the concentrations of cyclic AMP and cyclic GMP in neutrophils were assessed during cell contact with phagocytizable particles and autonomic agents. The model system employed for study was the interaction of purified human neutrophils with rheumatoid arthritic (RA) serum-treated zymosan particles at 37 degrees C in a neutral, balanced salt solution containing glucose. Neutrophils ingested the particles and discharged beta-glucuronidase but not lactate dehydrogenase activity during 30 min of incubation. Treatment of zymosan particles with RA serum was more effective than treatment with normal serum with regard to the extent of both particle uptake and lysosomal enzyme release. During contact of neutrophils with RA serum-treated zymosan particles epinephrine, isoproterenol, and cyclic AMP inhibited both particle ingestion and beta-glucuronidase discharge. These actions of epinephrine were associated with a concomitant elevation of cyclic AMP levels. In contrast to the actions of catecholamines and cyclic AMP, acetylcholine and cyclic GMP accelerated lysosomal enzyme release without affecting particle uptake. The actions of acetylcholine were associated with a concomitant elevation of cyclic GMP levels. Increases in neutrophil levels of cyclic GMP but not of cyclic AMP were associated also with the discharge of beta-glucuronidase provoked by particles in the absence of added cholinergic agents. The data suggest that the immunologic release of lysosomal enzymes from human neutrophils can be regulated by autonomic neurohormones, perhaps via the selective formation of appropriate nucleotides.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4364334      PMCID: PMC2139682          DOI: 10.1084/jem.139.6.1395

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  48 in total

1.  SEPARATION OF LYMPHOCYTES, POLYMORPHONUCLEAR LEUKOCYTES AND MONOCYTES ON GLASS COLUMNS, INCLUDING TISSUE CULTURE OBSERVATIONS.

Authors:  Y RABINOWITZ
Journal:  Blood       Date:  1964-06       Impact factor: 22.113

2.  Inhibition of lysosomal enzyme release by adenosine 5' triphosphate and N 6 ,O 2 -dibutyryl cyclic 3',5'-adenosine monophosphate.

Authors:  L J Ignarro; N Krassikoff; J Slywka
Journal:  Life Sci I       Date:  1972-04-01

3.  Prevention of experimental allergic encephalomyelitis by combination of epinephrine and a phenothiazine derivative, propiomazine.

Authors:  E C Henson; J G Brunson
Journal:  Proc Soc Exp Biol Med       Date:  1969-07

4.  Lysosomal enzyme release from human leukocytes: mediation by the alternate pathway of complement activation.

Authors:  I M Goldstein; M Brai; A G Osler; G Weissmann
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

5.  Release of histamine and lysosomal enzymes by human leukocytes during phagocytosis of staphylococci.

Authors:  J G Crowder; R R Martin; A White
Journal:  J Lab Clin Med       Date:  1969-09

6.  Glomerular basement membrane damage in immunological glomerulonephritis.

Authors:  D Hawkins; C G Cochrane
Journal:  Immunology       Date:  1968-05       Impact factor: 7.397

7.  The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles.

Authors:  P M Henson
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

8.  The effect of polystyrene beads on cyclic 3',5'-adenosine monophosphate concentration in leukocytes.

Authors:  V Manganiello; W H Evans; T P Stossel; R J Mason; M Vaughan
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

9.  Cyclic adenosine monophosphate in phagocytizing granulocytes and alveolar macrophages.

Authors:  H W Seyberth; H Schmidt-Gayk; K H Jakobs; E Hackenthal
Journal:  J Cell Biol       Date:  1973-05       Impact factor: 10.539

10.  The depression of phagocytosis by exogenous cyclic nucleotides, prostaglandins, and theophylline.

Authors:  J P Cox; M L Karnovsky
Journal:  J Cell Biol       Date:  1973-11       Impact factor: 10.539

View more
  24 in total

1.  The effect of serotonin (5-hydroxytryptamine) and derivatives on guanosine 3',5'-monophosphate in human monocytes.

Authors:  J A Sandler; R I Clyman; V C Manganiello; M Vaughan
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

2.  Bioregulation of lysosomal enzyme secretion from human neutrophils: roles of guanosine 3':5'-monophosphate and calcium in stimulus-secretion coupling.

Authors:  R J Smith; L J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

Review 3.  Regulation of lysosomal enzyme secretion: role in inflammation.

Authors:  L J Ignarro
Journal:  Agents Actions       Date:  1974-10

4.  Eosinophil degranulation. Monitoring by interference contrast microscopy.

Authors:  R Sher; A A Wadee
Journal:  Inflammation       Date:  1981-03       Impact factor: 4.092

5.  [Phagocytosis mechanisms of alveolar macrophages and granulocytes (author's transl)].

Authors:  M Rister
Journal:  Blut       Date:  1980-10

6.  NPC 15669-modulated human polymorphonuclear neutrophil functional responsiveness: effects on receptor-coupled signal transduction.

Authors:  R J Smith; J M Justen; J E Bleasdale; L M Sly
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

7.  The effect of D-penicillamine on polymorphonuclear leukocyte function.

Authors:  H Chwalinska-Sadowska; J Baum
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

8.  Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid.

Authors:  B B Vargaftig; M Chignard
Journal:  Agents Actions       Date:  1975-05

9.  Stimulation by alcohols of cyclic AMP metabolism in human leukocytes. Possible role of cyclic AMP in the anti-inflammatory effects of ethanol.

Authors:  J P Atkinson; T J Sullivan; J P Kelly; C W Parker
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

10.  Activation of the human neutrophil secretory process with 5(S),12(R)-dihydroxy-6,14-cis-8,10-trans-eicosatetraenoic acid.

Authors:  R J Smith; S S Iden; B J Bowman
Journal:  Inflammation       Date:  1984-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.